Article Details

As Five Prime Therapeutics (FPRX) Market Valuation Declined, Bvf Has Cut Position; Bridgecreek ...

Retrieved on: 2019-06-01 23:10:12

Tags for this article:

Click the tags to see associated articles and topics

As Five Prime Therapeutics (FPRX) Market Valuation Declined, Bvf Has Cut Position; Bridgecreek .... View article details on hiswai:

Excerpt

<div>... Prime Therapeutics' Targeted Immuno-Oncology Drug Candidate Bemarituzumab; 14/05/2018 – <b>Renaissance Technologies</b> Buys New 1% Position ...</div>

Article found on:

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up